Literature DB >> 16242144

Generation of metabolic oscillations by mitoKATP and ATP synthase during simulated ischemia in ventricular myocytes.

Shin-Young Ryu1, Suk-Ho Lee, Won-Kyung Ho.   

Abstract

Metabolic oscillations and the concomitant periodic activations of sarcolemmal ATP-sensitive K(+) channels (sarcK(ATP)) have recently been proposed as one mechanism underlying ischemia-related arrhythmia. In this study, we investigated the role of mitochondrial ATP-sensitive K(+) channels (mitoK(ATP)) and ATP synthase in the generation of metabolic oscillations during simulated ischemia from rat ventricular myocytes using patch-clamp technique and fluorescence microscopy. We have found that the combined application of creatine kinase (CK) inhibitor, 2,4-dinitrofluorobenzene, with cyanide, electron-transport-chain inhibitor causes oscillatory activations of sarcK(ATP). The oscillatory activations of sarcK(ATP) were accompanied by large periodic depolarizations in mitochondrial membrane potential (Psi(m)). 5-Hydroxydecanoate, an inhibitor of mitoK(ATP), halted the oscillations in Psi(m) at repolarized state, whereas oligomycin, an inhibitor of ATP synthase, halted them at depolarized state. In both conditions, oscillatory activations of sarcK(ATP) were abolished. Inhibitors of adenine nucleotide translocator and permeability transition pore had no effect on the oscillations in Psi(m) and sarcK(ATP). 4,4'-diisothiocyanatostilbene-2,2'-disulfonate, an inhibitor of mitochondrial inner-membrane anion channel (IMAC), caused a full depolarization in Psi(m) and activation of sarcK(ATP), finally resulting in irreversible hypercontracture. Taken together, oscillations in Psi(m) can be explained by balance between depolarizing power of mitoK(ATP) and repolarizing power of the reverse activity of ATP synthase. ATP consumption by ATP synthase in reverse mode links periodic depolarizations in Psi(m) to oscillatory activation of sarcK(ATP). Considering that such oscillations were not induced by cyanide alone, CK system may act as an important buffer, inhibiting arrhythmia during ischemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242144     DOI: 10.1016/j.yjmcc.2005.08.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

Review 1.  Mitochondria are sources of metabolic sink and arrhythmias.

Authors:  Fadi G Akar; Brian O'Rourke
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Glycolytic oscillations in isolated rabbit ventricular myocytes.

Authors:  Jun-Hai Yang; Ling Yang; Zhilin Qu; James N Weiss
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

Review 3.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 4.  Cardiac mitochondria and arrhythmias.

Authors:  David A Brown; Brian O'Rourke
Journal:  Cardiovasc Res       Date:  2010-07-09       Impact factor: 10.787

Review 5.  Redox control of cardiac excitability.

Authors:  Nitin T Aggarwal; Jonathan C Makielski
Journal:  Antioxid Redox Signal       Date:  2012-08-16       Impact factor: 8.401

Review 6.  Mitochondria and arrhythmias.

Authors:  Kai-Chien Yang; Marcelo G Bonini; Samuel C Dudley
Journal:  Free Radic Biol Med       Date:  2014-04-05       Impact factor: 7.376

7.  Single channel characterization of the mitochondrial ryanodine receptor in heart mitoplasts.

Authors:  Shin-Young Ryu; Gisela Beutner; Kathleen W Kinnally; Robert T Dirksen; Shey-Shing Sheu
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

8.  Oscillations at odds in the heart.

Authors:  James N Weiss; Jun-Hai Yang
Journal:  J Gen Physiol       Date:  2010-03-15       Impact factor: 4.086

9.  Glycolytic oscillations in single ischemic cardiomyocytes at near anoxia.

Authors:  Vladimir Ganitkevich; Violeta Mattea; Klaus Benndorf
Journal:  J Gen Physiol       Date:  2010-03-15       Impact factor: 4.086

Review 10.  Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Konstantinos E Iliodromitis; Sotiria G Giotaki; Charalampos Kossyvakis; Konstantinos Raisakis; Andreas Kaoukis; Vaia Lambadiari; Dimitrios Avramides; Bernhard Reimers; Giulio G Stefanini; Michael Cleman; Georgios Giannopoulos; Alexandra Lansky; Spyridon G Deftereos
Journal:  Drugs       Date:  2021-07-23       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.